We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

28 hedge funds and large institutions have $1.55M invested in T2 Biosystems, Inc in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

257% more call options, than puts

Call options by funds: $25K | Put options by funds: $7K

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

131% more capital invested

Capital invested by funds: $672K → $1.55M (+$880K)

40% more funds holding

Funds holding: 2028 (+8)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
28
Holders Change
+8
Holders Change %
+40%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
3
Reduced
6
Closed
4
Calls
$25K
Puts
$7K
Net Calls
+$18K
Net Calls Change
-$65K

TTOO Hedge Fund Activity: Q1 2023 in Review

28 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2023, worth a combined $1.55M — up 131% from $672K a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new TTOO positions and 4 closed out — a net gain of 8 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $818K. The largest seller was McAdam LLC, exiting entirely with an estimated $58K sold.

  • 28 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2023, up from 20 in Q4 2022.
  • Funds reported $1.55M of T2 Biosystems, Inc stock for Q1 2023, up 131% quarter-over-quarter.
  • 12 funds opened new T2 Biosystems, Inc positions in Q1 2023 and 4 closed out, a net change of +8 holders.
  • The largest T2 Biosystems, Inc buyer in Q1 2023 was Sabby Management, an estimated $818K added.
  • The largest T2 Biosystems, Inc seller in Q1 2023 was McAdam LLC, an estimated $58K sold.

Based on aggregated 13F filings for Q1 2023.